lymph node: is secondary cancer sites

Related concepts

Parents	tissue Weight: 0.70 , breast cancer Weight: 0.69 , bone marrow Weight: 0.68 , lymphatic system Weight: 0.64
Siblings	salivary gland Weight: 0.68 , spleen Weight: 0.63 , tonsil Weight: 0.63 , lymph Weight: 0.39

Related properties

Property	Similarity
is secondary cancer sites	1.00
is cancer sites	0.93
has state cancer	0.82
cancer	0.82
be more important than other cancer	0.80
be considered secondary tissue	0.79
be considered secondary organ	0.79
be removed with cancer	0.78
be more common than other cancers	0.78
be removed in cancer treatments	0.78

Priors about this statement

Cues

Evidence

Clauses

Plausibility inference from child typicality

0.46

Rule weight: 0.66
Evidence weight: 0.87
Similarity weight: 0.80

Evidence: 0.86

Plausible(breast cancer, be more important than other cancer) ⋁

Evidence: 0.99

¬ Typical(lymph node, is secondary cancer sites)

0.32

Rule weight: 0.66
Evidence weight: 0.61
Similarity weight: 0.78

Evidence: 0.61

Plausible(breast cancer, be more common than other cancers) ⋁

Evidence: 0.99

¬ Typical(lymph node, is secondary cancer sites)

0.18

Rule weight: 0.66
Evidence weight: 0.33
Similarity weight: 0.82

Evidence: 0.32

Plausible(breast cancer, has state cancer) ⋁

Evidence: 0.99

¬ Typical(lymph node, is secondary cancer sites)

Plausibility inheritance from parent to child

0.08

Rule weight: 0.09
Evidence weight: 0.98
Similarity weight: 0.82

Evidence: 0.95

Plausible(lymph node, is secondary cancer sites) ⋁

Evidence: 0.32

¬ Plausible(breast cancer, has state cancer)

0.07

Rule weight: 0.09
Evidence weight: 0.96
Similarity weight: 0.80

Evidence: 0.95

Plausible(lymph node, is secondary cancer sites) ⋁

Evidence: 0.86

¬ Plausible(breast cancer, be more important than other cancer)

0.07

Rule weight: 0.09
Evidence weight: 0.97
Similarity weight: 0.78

Evidence: 0.95

Plausible(lymph node, is secondary cancer sites) ⋁

Evidence: 0.61

¬ Plausible(breast cancer, be more common than other cancers)

Remarkability exclusitivity betweem a parent and a child

0.31

Rule weight: 0.58
Evidence weight: 0.67
Similarity weight: 0.80

Evidence: 0.51

¬ Remarkable(lymph node, is secondary cancer sites) ⋁

Evidence: 0.65

¬ Remarkable(breast cancer, be more important than other cancer)

0.27

Rule weight: 0.58
Evidence weight: 0.59
Similarity weight: 0.78

Evidence: 0.51

¬ Remarkable(lymph node, is secondary cancer sites) ⋁

Evidence: 0.80

¬ Remarkable(breast cancer, be more common than other cancers)

0.26

Rule weight: 0.58
Evidence weight: 0.56
Similarity weight: 0.82

Evidence: 0.51

¬ Remarkable(lymph node, is secondary cancer sites) ⋁

Evidence: 0.86

¬ Remarkable(breast cancer, has state cancer)

Remarkability exclusitivity between siblings

0.09

Rule weight: 0.13
Evidence weight: 0.78
Similarity weight: 0.82

Evidence: 0.51

¬ Remarkable(lymph node, is secondary cancer sites) ⋁

Evidence: 0.42

¬ Remarkable(tonsil, has state cancer)

0.08

Rule weight: 0.13
Evidence weight: 0.79
Similarity weight: 0.78

Evidence: 0.51

¬ Remarkable(lymph node, is secondary cancer sites) ⋁

Evidence: 0.40

¬ Remarkable(spleen, be removed with cancer)

0.08

Rule weight: 0.13
Evidence weight: 0.73
Similarity weight: 0.82

Evidence: 0.51

¬ Remarkable(lymph node, is secondary cancer sites) ⋁

Evidence: 0.54

¬ Remarkable(tonsil, cancer)

0.08

Rule weight: 0.13
Evidence weight: 0.74
Similarity weight: 0.79

Evidence: 0.51

¬ Remarkable(lymph node, is secondary cancer sites) ⋁

Evidence: 0.50

¬ Remarkable(spleen, be considered secondary organ)

Remarkability from parent implausibility

0.32

Rule weight: 0.42
Evidence weight: 0.94
Similarity weight: 0.80

Evidence: 0.86

Plausible(breast cancer, be more important than other cancer) ⋁

Evidence: 0.51

Remarkable(lymph node, is secondary cancer sites) ⋁

Evidence: 0.95

¬ Plausible(lymph node, is secondary cancer sites)

0.27

Rule weight: 0.42
Evidence weight: 0.82
Similarity weight: 0.78

Evidence: 0.61

Plausible(breast cancer, be more common than other cancers) ⋁

Evidence: 0.51

Remarkable(lymph node, is secondary cancer sites) ⋁

Evidence: 0.95

¬ Plausible(lymph node, is secondary cancer sites)

0.24

Rule weight: 0.42
Evidence weight: 0.69
Similarity weight: 0.82

Evidence: 0.32

Plausible(breast cancer, has state cancer) ⋁

Evidence: 0.51

Remarkable(lymph node, is secondary cancer sites) ⋁

Evidence: 0.95

¬ Plausible(lymph node, is secondary cancer sites)

Remarkability from sibling implausibility

0.48

Rule weight: 0.60
Evidence weight: 0.98
Similarity weight: 0.82

Evidence: 0.95

Plausible(lymph node, is secondary cancer sites) ⋁

Evidence: 0.54

Remarkable(tonsil, cancer) ⋁

Evidence: 0.85

¬ Plausible(tonsil, cancer)

0.48

Rule weight: 0.60
Evidence weight: 0.98
Similarity weight: 0.82

Evidence: 0.95

Plausible(lymph node, is secondary cancer sites) ⋁

Evidence: 0.42

Remarkable(tonsil, has state cancer) ⋁

Evidence: 0.84

¬ Plausible(tonsil, has state cancer)

0.46

Rule weight: 0.60
Evidence weight: 0.98
Similarity weight: 0.79

Evidence: 0.95

Plausible(lymph node, is secondary cancer sites) ⋁

Evidence: 0.50

Remarkable(spleen, be considered secondary organ) ⋁

Evidence: 0.96

¬ Plausible(spleen, be considered secondary organ)

0.46

Rule weight: 0.60
Evidence weight: 0.98
Similarity weight: 0.78

Evidence: 0.95

Plausible(lymph node, is secondary cancer sites) ⋁

Evidence: 0.40

Remarkable(spleen, be removed with cancer) ⋁

Evidence: 0.77

¬ Plausible(spleen, be removed with cancer)

Salient implies Plausible

0.27

Rule weight: 0.28
Evidence weight: 0.95
Similarity weight: 1.00

Evidence: 0.95

Plausible(lymph node, is secondary cancer sites) ⋁

Evidence: 0.98

¬ Salient(lymph node, is secondary cancer sites)

Similarity expansion

0.78

Rule weight: 0.85
Evidence weight: 0.99
Similarity weight: 0.93

Evidence: 0.99

Typical(lymph node, is secondary cancer sites) ⋁

Evidence: 0.91

¬ Typical(lymph node, is cancer sites)

0.78

Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.93

Evidence: 0.98

Salient(lymph node, is secondary cancer sites) ⋁

Evidence: 0.83

¬ Salient(lymph node, is cancer sites)

0.76

Rule weight: 0.85
Evidence weight: 0.96
Similarity weight: 0.93

Evidence: 0.95

Plausible(lymph node, is secondary cancer sites) ⋁

Evidence: 0.83

¬ Plausible(lymph node, is cancer sites)

0.66

Rule weight: 0.85
Evidence weight: 0.99
Similarity weight: 0.78

Evidence: 0.99

Typical(lymph node, is secondary cancer sites) ⋁

Evidence: 0.78

¬ Typical(lymph node, be removed in cancer treatments)

0.66

Rule weight: 0.85
Evidence weight: 0.99
Similarity weight: 0.78

Evidence: 0.98

Salient(lymph node, is secondary cancer sites) ⋁

Evidence: 0.42

¬ Salient(lymph node, be removed in cancer treatments)

0.65

Rule weight: 0.85
Evidence weight: 0.97
Similarity weight: 0.78

Evidence: 0.95

Plausible(lymph node, is secondary cancer sites) ⋁

Evidence: 0.56

¬ Plausible(lymph node, be removed in cancer treatments)

0.61

Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.93

Evidence: 0.51

Remarkable(lymph node, is secondary cancer sites) ⋁

Evidence: 0.45

¬ Remarkable(lymph node, is cancer sites)

0.58

Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.78

Evidence: 0.51

Remarkable(lymph node, is secondary cancer sites) ⋁

Evidence: 0.26

¬ Remarkable(lymph node, be removed in cancer treatments)

Typical and Remarkable implies Salient

0.14

Rule weight: 0.14
Evidence weight: 0.99
Similarity weight: 1.00

Evidence: 0.98

Salient(lymph node, is secondary cancer sites) ⋁

Evidence: 0.99

¬ Typical(lymph node, is secondary cancer sites) ⋁

Evidence: 0.51

¬ Remarkable(lymph node, is secondary cancer sites)

Typical implies Plausible

0.46

Rule weight: 0.48
Evidence weight: 0.95
Similarity weight: 1.00

Evidence: 0.95

Plausible(lymph node, is secondary cancer sites) ⋁

Evidence: 0.99

¬ Typical(lymph node, is secondary cancer sites)

Typicality and Rermarkability incompatibility between a parent and a child

0.38

Rule weight: 0.51
Evidence weight: 0.91
Similarity weight: 0.82

Evidence: 0.51

¬ Remarkable(lymph node, is secondary cancer sites) ⋁

Evidence: 0.17

¬ Typical(breast cancer, has state cancer)

0.28

Rule weight: 0.51
Evidence weight: 0.71
Similarity weight: 0.78

Evidence: 0.51

¬ Remarkable(lymph node, is secondary cancer sites) ⋁

Evidence: 0.57

¬ Typical(breast cancer, be more common than other cancers)

0.22

Rule weight: 0.51
Evidence weight: 0.53
Similarity weight: 0.80

Evidence: 0.51

¬ Remarkable(lymph node, is secondary cancer sites) ⋁

Evidence: 0.91

¬ Typical(breast cancer, be more important than other cancer)

Typicality and Rermarkability incompatibility between siblings

0.07

Rule weight: 0.14
Evidence weight: 0.65
Similarity weight: 0.79

Evidence: 0.51

¬ Remarkable(lymph node, is secondary cancer sites) ⋁

Evidence: 0.68

¬ Typical(spleen, be considered secondary organ)

0.06

Rule weight: 0.14
Evidence weight: 0.53
Similarity weight: 0.82

Evidence: 0.51

¬ Remarkable(lymph node, is secondary cancer sites) ⋁

Evidence: 0.91

¬ Typical(tonsil, cancer)

0.06

Rule weight: 0.14
Evidence weight: 0.55
Similarity weight: 0.78

Evidence: 0.51

¬ Remarkable(lymph node, is secondary cancer sites) ⋁

Evidence: 0.88

¬ Typical(spleen, be removed with cancer)

0.06

Rule weight: 0.14
Evidence weight: 0.52
Similarity weight: 0.82

Evidence: 0.51

¬ Remarkable(lymph node, is secondary cancer sites) ⋁

Evidence: 0.94

¬ Typical(tonsil, has state cancer)

Typicality inheritance from parent to child

0.40

Rule weight: 0.48
Evidence weight: 1.00
Similarity weight: 0.82

Evidence: 0.99

Typical(lymph node, is secondary cancer sites) ⋁

Evidence: 0.17

¬ Typical(breast cancer, has state cancer)

0.39

Rule weight: 0.48
Evidence weight: 0.99
Similarity weight: 0.80

Evidence: 0.99

Typical(lymph node, is secondary cancer sites) ⋁

Evidence: 0.91

¬ Typical(breast cancer, be more important than other cancer)

0.38

Rule weight: 0.48
Evidence weight: 0.99
Similarity weight: 0.78

Evidence: 0.99

Typical(lymph node, is secondary cancer sites) ⋁

Evidence: 0.57

¬ Typical(breast cancer, be more common than other cancers)